The Association Between Recombinant Tissue Plasminogen Activator and Post-ischemic Stroke Seizure: A Retrospective Cohort Study
Background: Recombinant tissue plasminogen activator (r-tPA) has remained the primary therapeutic intervention for ischemic stroke when administered within the recommended time window. Despite its well-established benefits, potential side effects—glutamate release, increased leukocyte activity, and...
Saved in:
| Main Authors: | Hanie Khoshtarash, Alia Saberi, Hamidreza Hatamian, Ali Ashraf, Somayeh Ahmadi, Mohammad Ali Yazdanipour |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Guilan University of Medical Sciences
2025-07-01
|
| Series: | Caspian Journal of Neurological Sciences |
| Subjects: | |
| Online Access: | http://cjns.gums.ac.ir/article-1-780-en.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tissue plasminogen activator and patients with acute ischemic stroke: The litigation landscape
by: Latha Ganti, et al.
Published: (2022-02-01) -
Early-Onset Seizures in Ischemic Stroke: A Descriptive Cross-Sectional Study
by: Mohsina Syed, et al.
Published: (2022-07-01) -
Ischemic stroke with unknown onset of symptoms: current scenario and perspectives for the future
by: Rônney Pinto Lopes, et al.
Published: (2022-12-01) -
Demographic, clinical and radiological characteristics of patients with acute ischemic stroke and acute symptomatic seizures
by: Baljak Anja, et al.
Published: (2025-01-01) -
Effect of Plasma Soluble Urokinase-Type Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 Levels in the Plasma of Babylon Women with Breast Cancer
by: Sheerin H. Abbas, et al.
Published: (2025-01-01)